Oxford Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Oxford Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.43M	Buy	+15,000	New	+$1.47M	0.2%	78

Other funds holding JSPR

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Oxford Asset Management's JSPR Position: Q1 2020 in Review

Oxford Asset Management opened a new position in Jasper Therapeutics (JSPR) in Q1 2020: 15,000 shares worth $1.43M. The stake represents 0.2% of the portfolio and ranks #78 among its holdings.

28 funds tracked by Wall St. Rank hold JSPR as of Q1 2020.

Oxford Asset Management held 15,000 shares of Jasper Therapeutics worth $1.43M as of Q1 2020.
Jasper Therapeutics was a new Oxford Asset Management position in Q1 2020.
Jasper Therapeutics made up 0.2% of Oxford Asset Management's portfolio in Q1 2020, its #78 holding.
28 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.